[go: up one dir, main page]

DK1589023T3 - Oligosaccharid-derivat - Google Patents

Oligosaccharid-derivat

Info

Publication number
DK1589023T3
DK1589023T3 DK04706367.2T DK04706367T DK1589023T3 DK 1589023 T3 DK1589023 T3 DK 1589023T3 DK 04706367 T DK04706367 T DK 04706367T DK 1589023 T3 DK1589023 T3 DK 1589023T3
Authority
DK
Denmark
Prior art keywords
groups
pharmacologically acceptable
oligosaccharide derivative
group
chem
Prior art date
Application number
DK04706367.2T
Other languages
English (en)
Inventor
Takeshi Honda
Akira Okuno
Masanori Izumi
Xiaoliu Li
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of DK1589023T3 publication Critical patent/DK1589023T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
DK04706367.2T 2003-01-30 2004-01-29 Oligosaccharid-derivat DK1589023T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003022800 2003-01-30
PCT/JP2004/000879 WO2004067542A1 (ja) 2003-01-30 2004-01-29 オリゴ糖誘導体

Publications (1)

Publication Number Publication Date
DK1589023T3 true DK1589023T3 (da) 2010-12-13

Family

ID=32820702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04706367.2T DK1589023T3 (da) 2003-01-30 2004-01-29 Oligosaccharid-derivat

Country Status (21)

Country Link
US (2) US7361744B2 (da)
EP (1) EP1589023B1 (da)
KR (1) KR101050981B1 (da)
CN (2) CN100360548C (da)
AT (1) ATE478884T1 (da)
AU (1) AU2004207726B2 (da)
BR (1) BRPI0406990A (da)
CA (1) CA2514931A1 (da)
DE (1) DE602004028799D1 (da)
DK (1) DK1589023T3 (da)
ES (1) ES2349736T3 (da)
IL (1) IL169577A (da)
MX (1) MXPA05008190A (da)
NO (1) NO20053997L (da)
NZ (1) NZ541455A (da)
PL (1) PL377462A1 (da)
PT (1) PT1589023E (da)
RU (1) RU2290408C2 (da)
TW (1) TWI318202B (da)
WO (1) WO2004067542A1 (da)
ZA (1) ZA200506075B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200612968A (en) * 2004-07-29 2006-05-01 Sankyo Co Oligosaccharide derivatives containing with heterocycle
TW200608967A (en) * 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
TW200735880A (en) * 2006-01-27 2007-10-01 Sankyo Co Medicinal compositions for preventing or treating heart failure
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2056801T3 (es) * 1986-08-13 1994-10-16 Hoechst Ag Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4643775B2 (ja) * 1999-01-13 2011-03-02 日本食品化工株式会社 香気成分生成阻害剤
JP3909735B2 (ja) 1999-02-22 2007-04-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途
WO2000050494A1 (en) 1999-02-23 2000-08-31 Ips Corporation Low voc (volatile organic compounds), dimethyl-2-piperidone solvent-based, pvc and cpvc pipe and component adhesives and primers containing minimal or no tetrahydrofuran
JP4373671B2 (ja) * 2000-06-06 2009-11-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途

Also Published As

Publication number Publication date
CA2514931A1 (en) 2004-08-12
IL169577A (en) 2010-06-16
NO20053997L (no) 2005-10-28
RU2005124286A (ru) 2006-01-27
CN1768073A (zh) 2006-05-03
US20080194495A1 (en) 2008-08-14
ES2349736T3 (es) 2011-01-11
BRPI0406990A (pt) 2006-01-10
PT1589023E (pt) 2010-10-29
EP1589023A4 (en) 2008-12-10
EP1589023B1 (en) 2010-08-25
AU2004207726A1 (en) 2004-08-12
NZ541455A (en) 2007-08-31
IL169577A0 (en) 2007-07-04
TW200502204A (en) 2005-01-16
HK1077070A1 (en) 2006-02-03
RU2290408C2 (ru) 2006-12-27
US7632930B2 (en) 2009-12-15
CN100360548C (zh) 2008-01-09
PL377462A1 (pl) 2006-02-06
US20060025350A1 (en) 2006-02-02
KR20050094465A (ko) 2005-09-27
EP1589023A1 (en) 2005-10-26
CN101367851A (zh) 2009-02-18
DE602004028799D1 (en) 2010-10-07
AU2004207726B2 (en) 2007-03-15
ATE478884T1 (de) 2010-09-15
KR101050981B1 (ko) 2011-07-21
TWI318202B (en) 2009-12-11
MXPA05008190A (es) 2006-02-17
WO2004067542A1 (ja) 2004-08-12
US7361744B2 (en) 2008-04-22
NO20053997D0 (no) 2005-08-29
ZA200506075B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
DK1613304T3 (da) DPP-IV-inhibitorer
NO20054852L (no) GFAT inhibitorer
ATE532770T1 (de) Imidazolderivat
EP1736467A4 (en) NEW SULFONIC ACID AMID DERIVATIVE
EP1642880A4 (en) PROTEIN INHIBITORS OF THE HSP90 FAMILY
ATE358484T1 (de) Antidiabetische medikamente
NO20053762L (no) Kondensert furanforbindelse.
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
CY1111271T1 (el) Παραγωγο τριαζολονης
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
EP1634874A4 (en) imidazolidine
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
DK1589023T3 (da) Oligosaccharid-derivat
NO20055695L (no) Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer
EP2045258A4 (en) 3y-ETHYNYLCYTIDINDERIVAT
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
PT1175429E (pt) Derivados halo de 9-desoxo-9a-aza-9a-homoeritromicina a
EP1254907A4 (en) Pyrrolopyridazine CONNECTIONS
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
BRPI0511824A (pt) radiossensibilizador
EP1500656A4 (en) BIGUANIDE DERIVATIVE AND DIABETES TREATMENT AGENT CONTAINING
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.
TH62392A (th) อนุพันธ์ควิโนลีนและไพริดีนชนิดใหม่